NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill wipe out bladder tumors before surgery?
Disease control CompletedThis study tested a drug called pemigatinib in 30 people with a type of bladder cancer that keeps coming back. Participants took the drug for 4-6 weeks before their scheduled surgery to remove the tumor. The goal was to see if the drug could completely eliminate the cancer before…
Matched conditions: NMIBC
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Bladder cancer virus therapy shows promise in early trial
Disease control CompletedThis study tested a new treatment called VG161, a virus designed to attack cancer cells, for people with a type of bladder cancer that came back after standard therapy. The treatment was given directly into the bladder. The main goals were to check safety, find the best dose, and…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: Ding-Wei Ye • Aim: Disease control
Last updated May 17, 2026 05:09 UTC
-
New bladder cancer drug shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug called UGN-301 (zalifrelimab) in 51 people with recurrent non-muscle invasive bladder cancer. The drug was given directly into the bladder to see if it is safe and to find the best dose. The goal is to control the cancer and prevent it fro…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC